Maravai LifeSciences Holdings, Inc. Stock
Equities
MRVI
US56600D1072
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11 USD | -0.50% | -0.50% | +68.63% |
Financials (USD)
Sales 2024 * | 275M | Sales 2025 * | 303M | Capitalization | 1.47B |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -8M | EV / Sales 2024 * | 5.06 x |
Net cash position 2024 * | 73.18M | Net cash position 2025 * | 128M | EV / Sales 2025 * | 4.42 x |
P/E ratio 2024 * |
-50.8
x | P/E ratio 2025 * |
-104
x | Employees | 570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.44% |
Latest transcript on Maravai LifeSciences Holdings, Inc.
1 day | -1.67% | ||
1 week | -1.85% | ||
Current month | +32.87% | ||
1 month | +41.13% | ||
3 months | +30.32% | ||
6 months | +103.64% | ||
Current year | +66.34% |
Managers | Title | Age | Since |
---|---|---|---|
William Martin
CEO | Chief Executive Officer | 49 | 22-09-29 |
Carl Hull
FOU | Founder | 66 | 14-02-28 |
Kevin Herde
DFI | Director of Finance/CFO | 53 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | 16-02-29 |
Sean Cunningham
BRD | Director/Board Member | 48 | 16-02-29 |
Gregory Lucier
BRD | Director/Board Member | 59 | 19-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 12 M€ | -.--% | - | |
0.37% | 8 M€ | 0.00% | ||
0.34% | 2 M€ | 0.00% | ||
0.28% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 11.05 | 0.00% | 320 124 |
24-05-22 | 11.05 | +0.91% | 1,592,278 |
24-05-21 | 10.95 | -3.44% | 1,160,987 |
24-05-20 | 11.34 | +0.18% | 1,947,740 |
24-05-17 | 11.32 | +1.98% | 1,655,169 |
Delayed Quote Nasdaq, May 23, 2024 at 10:11 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.34% | 1.47B | |
-30.48% | 9.87B | |
-16.78% | 2.75B | |
-15.31% | 2.13B | |
-24.83% | 1.65B | |
+28.42% | 811M | |
-5.02% | 733M | |
-31.86% | 510M | |
+1.59% | 300M | |
-24.93% | 166M |
- Stock Market
- Equities
- MRVI Stock